Dobesilate in the treatment of plaque psoriasis

European Journal of Medical Research

Volumn 10, Issue 9, 2005, Pages 373-376

  Cuevas, Pedro ^a   Arrazola, José María ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Dobesilate; Plaque psoriasis; Topical therapy

Indexed keywords

2,5 DIHYDROXYBENZENESULFONIC ACID; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR; HYDROQUINONE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; DRUG TARGETING; DRUG USE; HUMAN; MALE; OUTCOMES RESEARCH; PATHOGENESIS; PSORIASIS VULGARIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SKIN ATROPHY;

ADULT; CALCIUM DOBESILATE; FIBROBLAST GROWTH FACTORS; HEMOSTATICS; HUMANS; MALE; PSORIASIS;

EID: 25444468047     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Christophers E (2001) Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol 26: 314-320
2. National Psoriasis Foundation. Facts About Psoriasis: htp://www.psoriasis.org. Accessed 11/21/04
3. Fortune DG, Mian CJ, O'Sullivan TM, Griffiths CEM (1997) Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 137: 255-260
4. Barker JNWN (1991) Pathophysiology of psoriasis. Lancet 338: 227-230
5. Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127: 871-884
6. Wrone-Smith T, Mitra RS, Thompson CB, Jasty R, Castle VP, Nickoloff BJ. (1997) Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 151: 11321-11329
7. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31
8. Wang F, McKeehan WL (2003) Handbook of Cell Signaling. Vol. 1 (Bradshaw R and Denis E, eds) pp. 265-270, Academic/Elsevier Press, New York
9. Tan Y, Low KG, Boccia C, Grossman J, Comb MJ (1994) Fibroblast growth factor and cyclic AMP (cAMP) synergistically activate gene expression at a cAMP response element. Mol Cell Biol 17: 7546-7556
10. Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L, Kerr LD (1998) Inhibition of NF-kB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis. Nature 392: 615-618
11. Geller SF, Lewis GP, Fisher SK (2001) FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Muller and RPE cells. Invest Ophthalmol Vis Sci 42: 1363-1369
12. Byrd VM, Ballard DW, Miller GG, Thomas JW (1999) Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kB in FGF receptor-bearing Jurkat T cells. J Inmunol 162: 5853-5859
13. Reilly JF, Maher PA (2001) Importinb-mediated nuclear import fibroblast growth factor receptor: role in cell proliferation. J Cell Biol 152: 1307-1312
14. Schlessinger J (2004) Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306: 1506-1507
15. Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells and inmune surveillance. New Engl J Med 341: 1817-1828
16. Kaufman CK, Fuchs E (2000) It's got you covered: NF-kB in the epidermis. J Cell Biol 29: 999-1004
17. Miracco C, Pellegrino M, Flori M, Vatti R, Materno M, Andreassi L (2000) Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment. Br J Dermatol 143: 950-956
18. Haase I, Hobbs RM, Romero R, Broat S, Watt FM (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108: 527-536
19. Sano S, Chan KS, Carbajal S, Clifford J, Peavey M, Kiguchi K, Itami S, Nickoloff BJ, Digiovanni J (2005) Stat 3 links activated keratinocytes and inmunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11: 43-49
20. Carmena-Ramón R, Cuevas-Sánchez B, Fernández-Ayerdi A, Barriandrés-Rodriguez O, Gárate-Ayastay MT, Arrazola-Mayona JM, García-Gómez I, Cuevas P. (2002) Niveles séricos del factor de crecimiento para fibroblastos básico (bFGF) en la psoriasis. Actas Dermatosifilog 93 (S2): 53
21. Berthet Ph, Farine JC, Borras JP (1999) Calcium dobesilate (Doxium"). Pharmacological profile related to its use in diabetic retinopathy. Int J Clin Pract 53: 631-636
22. Parés-Herbute N, Fliche E, Monnier L (1999) Involvement of nitric oxide in the inhibition of aortic smooth muscle cell proliferation by calcium dobesilate. Int J Angiol 8: 5-10
23. Cuevas P, Díaz-González D, Dujovny M (2005) Dihidroxy-2,5 benzenesulfonate (dobesilate) elicits growth arrest and apoptosis in glioma cells. Neurol Res (in press).
24. Ashcroft DM, Li Wan PA, Griffiths CE (2000) Therapeutic strategies for psoriasis. J Clin Pharm Ther 25: 1-10
25. Van de Kerkoff P (2003) Papulosquamous and eczematous dermatoses: psoriasis. In: Bologna JL, Jorizzo JL, Rapini RP, Editors. Dermatology St. Louis: Mosby p 125-149
26. Mills CM, Marks R (1993) Side effects of topical glucocorticoids. Curr Probl Dermatol 21: 122-131
27. Kragballe K (1992) Treatment of psoriasis with calcipotriol and another vitamin D analogues. J Am Acad. Dermatol 27: 1001-1008
28. Piller NB (1990) Assessment of the anti-inflammatory action of calcium dobesilate. Effect on macrophage attaching to subcutaneously implanted coverslip in guinea pigs. Arzneimitelforschung 40: 698-700
29. Bos JD, De Rie MA (1999) The pathogenesis of psoriasis: Inmunological facts and speculations. Immunol Today 20: 40-46
30. Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M (1994) T Lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: mitogens for vascular cells and fibroblasts: differential production and release CD4+ and CD8+ cells. Proc. Natl Acad Sci USA 91: 2890-2894
31. Zhao X-M, Byrd VM, McKeehnan WL, Reich MB, Miller GG; Thomas JM (1995) Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor). J Immunol 155: 3904-3911
32. Byrd V, Zhao X-M, McKeehnan WL, Miller GG, Thomas JW (1996) Expression and functional expansion of fibroblast growth factor receptor T cells in rheumatoid synovium and peripheral blood patients wtih rheumatoid arthritis. Arthritis Rheum 39: 914-922